Ascentage Pharma Group International

AAPG · HONG

$15.44+$0.52 (+3.49%)TodayMarket closed ·
Prev close $14.92

Who owns AAPG

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 32.5% of AAPG’s shares.

  • Takeda Pharmaceutical Company Limited6.5%
  • Yang (Dajun)6.2%
  • Zhai (Yifan)3.8%
  • Guo (Edward Ming)3.5%
  • Next 6 largest institutions12.6%
  • All other shareholders67.5%
Top institutional holders of AAPG
HolderShares% of shares
Takeda Pharmaceutical Company Limited24.31M6.48%
Yang (Dajun)23.15M6.17%
Zhai (Yifan)14.26M3.80%
Guo (Edward Ming)13.23M3.53%
China Universal Asset Management Co., Ltd.10.89M2.90%
Wang (Shaomeng)10.05M2.68%
Vanguard Capital Management, LLC9.37M2.50%
GF Fund Management Co., Ltd.7.70M2.05%
Norges Bank Investment Management (NBIM)4.80M1.28%
BlackRock Institutional Trust Company, N.A.4.26M1.14%

Largest mutual fund holders

Top mutual fund holders of AAPG
HolderShares% of shares
China Universal CNI HK Connect Innovative Drug Index ETF10.74M2.87%
GF CSI NCD AAA Index 7-Day Fund7.70M2.05%
Statens Pensjonsfond Utland4.80M1.28%
Vanguard Total International Stock Index Fund3.95M1.05%
Vanguard Emerging Markets Stock Index Fund (US)3.94M1.05%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of AAPG in the last 6 months.

Latest AAPG insider transactions
InsiderTypeSharesValue
Zhai YifanOption exercise95.58K—
Zhai YifanOption exercise92.75K—
Zhai YifanOption exercise95.58K—
Zhai YifanOption exercise92.75K—
Yang DajunOption exercise92.75K—
Yang DajunOption exercise95.58K—
Yang DajunOption exercise92.75K—
Yang DajunOption exercise95.58K—
Zhai YifanAward298.19K—
Zhai YifanAward298.19K—

Short interest

Settled Sep 30, 2026

Shares short
9.25K
Days to cover
1.48
% of shares outstanding
0.00%
Average daily volume
6.23K
Change since last report
−53.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.